Why equal treatment is not always equitable: the impact of existing ethnic health inequalities in cost-effectiveness modeling

被引:0
|
作者
Melissa McLeod
Tony Blakely
Giorgi Kvizhinadze
Ricci Harris
机构
[1] University of Otago Wellington,Department of Public Health
来源
关键词
Heterogeneity; Cost effectiveness; Equity; Māori; New Zealand; Ethnicity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach
    Dhankhar, Praveen
    Nwankwo, Chizoba
    Pillsbury, Matthew
    Lauschke, Andreas
    Goveia, Michelle G.
    Acosta, Camilo J.
    Elbasha, Elamin H.
    VALUE IN HEALTH, 2015, 18 (04) : 358 - 367
  • [42] Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis
    Vadagam, Pratyusha
    Kamal, Khalid M.
    Covvey, Jordan R.
    Giannetti, Vincent
    Mukherjee, Kumar
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (10): : 987 - +
  • [43] Cost-Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence
    Hiligsmann, Mickael
    Gathon, Henry-Jean
    Bruyere, Olivier
    Ethgen, Olivier
    Rabenda, Veronique
    Reginster, Jean-Yves
    VALUE IN HEALTH, 2010, 13 (04) : 394 - 401
  • [44] Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis
    McLeod, Melissa
    Sandiford, Peter
    Kvizhinadze, Giorgi
    Bartholomew, Karen
    Crengle, Sue
    BMJ OPEN, 2020, 10 (09):
  • [45] Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free
    Zijlstra, T. R.
    Braakman-Jansen, L. M. A.
    Taal, E.
    Rasker, J. J.
    van de Laar, M. A. F. J.
    RHEUMATOLOGY, 2007, 46 (09) : 1454 - 1459
  • [46] A COST-EFFECTIVENESS MODEL TO GUIDE HEALTH POLICY IN BIPOLAR DISORDER TREATMENT
    Chatterton, M. L.
    Mihalopoulos, C.
    Barendregt, J.
    Berk, M.
    Mitchell, P. B.
    Khoo, J.
    Carter, R.
    VALUE IN HEALTH, 2015, 18 (03) : A122 - A122
  • [47] Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness
    Chen, Huey-Fen
    Rose, Angela M.
    Waisbren, Susan
    Ahmad, Ayesha
    Prosser, Lisa A.
    CHILDREN-BASEL, 2021, 8 (05):
  • [48] Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions
    Farkouh, Raymond A.
    Klok, Rogier M.
    Postma, Maarten J.
    Roberts, Craig S.
    Strutton, David R.
    EXPERT REVIEW OF VACCINES, 2012, 11 (10) : 1235 - 1247
  • [49] IMPLICATIONS OF INFLATION REDUCTION ACT (IRA) ON BUDGET IMPACT AND COST-EFFECTIVENESS MODELING
    Aggarwal, S.
    Topaloglu, J.
    Kumar, S.
    Bela, A.
    Topaloglu, O.
    VALUE IN HEALTH, 2023, 26 (06) : S222 - S222
  • [50] Using Common Random Numbers in Health Care Cost-Effectiveness Simulation Modeling
    Murphy, Daniel R.
    Klein, Robert W.
    Smolen, Lee J.
    Klein, Timothy M.
    Roberts, Stephen D.
    HEALTH SERVICES RESEARCH, 2013, 48 (04) : 1508 - 1525